Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Natalie Anne Marie Furney currently holds 235,166 shares of TAKEDA PHARMACEUTICAL CO LTD (TAK), valued at approximately $0. This represents their equity stake as Global General Counsel.
Based on SEC Form 4 filings, Natalie Anne Marie Furney has been a net neutral trader of TAK stock. They have purchased $0 and sold $0 worth of shares.
Natalie Anne Marie Furney's most recent insider trade was on Jul 1, 2026, when they sold 43,886 shares at $0.00 per share.
Natalie Anne Marie Furney serves as Global General Counsel at TAKEDA PHARMACEUTICAL CO LTD (TAK). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Natalie Anne Marie Furney holds the position of Global General Counsel at TAKEDA PHARMACEUTICAL CO LTD, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Natalie Anne Marie Furney has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Natalie Anne Marie Furney was on Jul 1, 2026, when they purchased $0 worth of TAK shares. This transaction involved 43,886 shares at N/A per share.
Natalie Anne Marie Furney currently owns 235,166 shares of TAKEDA PHARMACEUTICAL CO LTD (TAK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Natalie Anne Marie Furney's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Natalie Anne Marie Furney has 1 Form 4 filings on record as an insider at TAKEDA PHARMACEUTICAL CO LTD.
Set alerts for Natalie Anne Marie Furney and 40,000+ other insiders.